Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report

Contributed by: Business Wire

Logo

Business Wire logo

Images

The report discloses PCI's performance, targets, and strategy to achieve nine identified impact categories. (Photo: Business Wire)
The report discloses PCI's performance, targets, and strategy to achieve nine identified impact categories. (Photo: Business Wire)
Business Wire embedded0

Tags

Medical Supplies
Biotechnology
Manufacturing
Professional Services
Health
General Health
Pharmaceutical
Environmental, Social and Governance (ESG)
Transport
Logistics/Supply Chain Management
Packaging
ESG Report

More Like This

YPrime Releases Inaugural ESG Report, Reinforcing Commitment to Responsible Innovation in Clinical Research

PR Newswire associated0

GenScript Sets New Benchmark for Responsible Biotech Leadership with 2025 ESG Report

PR Newswire associated0

EPG Publishes Inaugural ESG Report, Establishing Baseline for Sustainable Global Expansion

Business Wire logo

Options Abound as Europe’s ESG Services Expand Rapidly

Curia Releases 2024 Environmental, Social and Governance (ESG) Report

2024 Pharma Quality Europe Sustainability Report

PQE Group Announces Release of 2024 Sustainability Report

PCI Pharma Services announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities.

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities

Netceed Sustainability Report 2025

Netceed Publishes Its First Environmental, Social and Governance Report